Chikungunya: a decade of burden in the Americas

William M. de Souza; Guilherme S. Ribeiro; Shirlene T.S. de Lima; Ronaldo de Jesus; Filipe R.R. Moreira; Charles Whittaker; Maria Anice M. Sallum; Christine V.F. Carrington; Ester C. Sabino; Uriel Kitron; Nuno R. Faria; Scott C. Weaver

doi:10.1016/j.lana.2023.100673

Chikungunya: a decade of burden in the Americas

William M. de Souza, Guilherme S. Ribeiro, Shirlene T.S. de Lima, Ronaldo de Jesus, Filipe R.R. Moreira, Charles Whittaker, Maria Anice M. Sallum, Christine V.F. Carrington, Ester C. Sabino, Uriel Kitron, Nuno R. Faria, Scott C. Weaver

Microbiology, Immunology, and Molecular Genetics

Producción científica: Review article › revisión exhaustiva

111 Citas (Scopus)

Resumen

In the Americas, one decade following its emergence in 2013, chikungunya virus (CHIKV) continues to spread and cause epidemics across the region. To date, 3.7 million suspected and laboratory-confirmed chikungunya cases have been reported in 50 countries or territories in the Americas. Here, we outline the current status and epidemiological aspects of chikungunya in the Americas and discuss prospects for future research and public health strategies to combat CHIKV in the region.

Idioma original	English
Número de artículo	100673
Publicación	The Lancet Regional Health - Americas
Volumen	30
DOI	https://doi.org/10.1016/j.lana.2023.100673
Estado	Published - feb 2024

Nota bibliográfica

Publisher Copyright:
© 2024 The Authors

Financiación

WMdS was supported by a Global Virus Network fellowship, Burroughs Wellcome Fund (#1022448), and Wellcome Trust–Digital Technology Development award (Climate Sensitive Infectious Disease Modelling; 226075/Z/22/Z). SCW was supported by National Institutes of Health grants AI12094, U01AI151801, and AI121452. NRF was supported by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship (grant no. 204311/Z/16/Z), by a Medical Research Council-São Paulo Research Foundation (FAPESP) CADDE partnership award (MR/S0195/1 and FAPESP 18/14389-0) and by Bill & Melinda Gates Foundation grant (INV-034540). CW was supported by Sir Henry Wellcome Postdoctoral Fellowship, reference 224190/Z/21/Z. GSR was supported by Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education (grant no. 88887.694502/2022-00), Brazilian National Council for Scientific and Technological Development (grant no. 311365/2021-3), Fundação de Amparo à Pesquisa do Estado da Bahia (grant no. PET0022/2016 and SUS0019/2021), and Program for Research Excellence, IGM-Fiocruz/2020.

Financiadores	Número del financiador
Sir Henry Wellcome Postdoctoral Fellowship
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Medical Research Council-São Paulo Research Foundation
Ministério da Educação	88887.694502/2022-00
Wellcome Trust	204311, 226075/Z/22/Z, 226075, 224190
Burroughs Wellcome Fund	1022448
UK Medical Research Council, Engineering and Physical Sciences Research Council	MR/S019510/1
Fundação de Amparo à Pesquisa do Estado da Bahia	PET0022/2016, SUS0019/2021
Bill and Melinda Gates Foundation	224190/Z/21, INV-034540
National Institutes of Health (NIH)	AI121452, AI12094, U01AI151801
Fundação de Amparo à Pesquisa do Estado de São Paulo	18/14389-0, MR/S0195/1
Conselho Nacional de Desenvolvimento Científico e Tecnológico	311365/2021-3
Royal Society Sir Henry Dale Fellowship	204311/Z/16/Z

ASJC Scopus subject areas

Internal Medicine
Health Policy
Public Health, Environmental and Occupational Health

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/j.lana.2023.100673

Otros archivos y enlaces

Citar esto

@article{2924a418adff404e8adf2389fa48df8c,

title = "Chikungunya: a decade of burden in the Americas",

abstract = "In the Americas, one decade following its emergence in 2013, chikungunya virus (CHIKV) continues to spread and cause epidemics across the region. To date, 3.7 million suspected and laboratory-confirmed chikungunya cases have been reported in 50 countries or territories in the Americas. Here, we outline the current status and epidemiological aspects of chikungunya in the Americas and discuss prospects for future research and public health strategies to combat CHIKV in the region.",

keywords = "Alphavirus, Americas, Arbovirus, Chikungunya virus, Mosquito-borne virus",

author = "\{de Souza\}, \{William M.\} and Ribeiro, \{Guilherme S.\} and \{de Lima\}, \{Shirlene T.S.\} and \{de Jesus\}, Ronaldo and Moreira, \{Filipe R.R.\} and Charles Whittaker and Sallum, \{Maria Anice M.\} and Carrington, \{Christine V.F.\} and Sabino, \{Ester C.\} and Uriel Kitron and Faria, \{Nuno R.\} and Weaver, \{Scott C.\}",

note = "Publisher Copyright: {\textcopyright} 2024 The Authors",

year = "2024",

month = feb,

doi = "10.1016/j.lana.2023.100673",

language = "English",

volume = "30",

journal = "The Lancet Regional Health - Americas",

issn = "2667-193X",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Chikungunya

T2 - a decade of burden in the Americas

AU - de Souza, William M.

AU - Ribeiro, Guilherme S.

AU - de Lima, Shirlene T.S.

AU - de Jesus, Ronaldo

AU - Moreira, Filipe R.R.

AU - Whittaker, Charles

AU - Sallum, Maria Anice M.

AU - Carrington, Christine V.F.

AU - Sabino, Ester C.

AU - Kitron, Uriel

AU - Faria, Nuno R.

AU - Weaver, Scott C.

PY - 2024/2

Y1 - 2024/2

N2 - In the Americas, one decade following its emergence in 2013, chikungunya virus (CHIKV) continues to spread and cause epidemics across the region. To date, 3.7 million suspected and laboratory-confirmed chikungunya cases have been reported in 50 countries or territories in the Americas. Here, we outline the current status and epidemiological aspects of chikungunya in the Americas and discuss prospects for future research and public health strategies to combat CHIKV in the region.

AB - In the Americas, one decade following its emergence in 2013, chikungunya virus (CHIKV) continues to spread and cause epidemics across the region. To date, 3.7 million suspected and laboratory-confirmed chikungunya cases have been reported in 50 countries or territories in the Americas. Here, we outline the current status and epidemiological aspects of chikungunya in the Americas and discuss prospects for future research and public health strategies to combat CHIKV in the region.

KW - Alphavirus

KW - Americas

KW - Arbovirus

KW - Chikungunya virus

KW - Mosquito-borne virus

UR - https://www.scopus.com/pages/publications/85182402692

UR - https://www.scopus.com/inward/citedby.url?scp=85182402692&partnerID=8YFLogxK

U2 - 10.1016/j.lana.2023.100673

DO - 10.1016/j.lana.2023.100673

M3 - Review article

AN - SCOPUS:85182402692

SN - 2667-193X

VL - 30

JO - The Lancet Regional Health - Americas

JF - The Lancet Regional Health - Americas

M1 - 100673

ER -

Chikungunya: a decade of burden in the Americas

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto